Alejandro Galindo
CIK 1821447 · EVP Endocrine Business Unit · last filed 2022-08-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.23M
Companies
1
Total Filings
17
Lifetime Open-Market Net
$324.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | EVP Endocrine Business Unit | 781,690 | $4.13 | $3.23M | $324.9K | 17 | 2022-08-24 |
Recent Filings · Page 2 of 2
17 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-02 | MNKD | Buy (P) | +2,334 | $7.4K | EDGAR |
| 2021-08-27 | MNKD | Tax (F) | −9,616 | -$47.2K | EDGAR |
| 2021-08-02 | MNKD | Buy (P) | +5,000 | $15.0K | EDGAR |
| 2021-05-20 | MNKD | Grant (A) | +144,000 | $0 | EDGAR |
| 2020-12-10 | MNKD | Buy (P) | +34,602 | $100.0K | EDGAR |
| 2020-12-10 | MNKD | Buy (P) | +34,602 | $100.0K | EDGAR |
| 2020-08-31 | MNKD | Grant (A) | +364,000 | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.